tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Terence Flynn, 103 are a HOLD (40.08%), 30 are a SELL (11.67%), 124 are a BUY (48.25%).
Analyst Terence Flynn, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 69.16% that have a potential upside of 23.61% achieved within 219 days.
Terence Flynn’s has documented 571 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 12-Nov-2024.
Analyst best performing recommendations are on ARVN (ARVINAS).
The best stock recommendation documented was for ARVN (ARVINAS) at 11/13/2023. The price target of $20 was fulfilled within 2 days with a profit of $3.41 (20.55%) receiving and performance score of 102.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$40
$9.64 (31.75%)
$35
1 months 7 days ago
(13-Nov-2024)
0/6 (0%)
$10.84 (37.17%)
Hold
$36
$5.64 (18.58%)
$33
1 months 15 days ago
(05-Nov-2024)
19/25 (76%)
$8.26 (29.78%)
143
Hold
$26
$-4.36 (-14.36%)
$32
1 months 25 days ago
(25-Oct-2024)
6/7 (85.71%)
$-0.09 (-0.34%)
64
Buy
$30
$-0.36 (-1.19%)
$37
1 months 25 days ago
(25-Oct-2024)
8/16 (50%)
$3.91 (14.99%)
342
Buy
$37
$6.64 (21.87%)
$39
1 months 25 days ago
(25-Oct-2024)
3/8 (37.5%)
$10.91 (41.82%)
101
Which stock is Terence Flynn is most bullish on?
Which stock is Terence Flynn is most reserved on?
What Year was the first public recommendation made by Terence Flynn?
